PET/MRI Perfusion and CT Perfusion in Solid Tumors

University of Zurich (UZH)

Status: Terminated

Conditions: CT Perfusion and MRI Perfusion in Solid Tumors

Study type: Observational

Funder types: Other

Identifiers

NCT02314962

KEK ZH Nr 20140077

Details and patient eligibility

About

Diagnostic comparison between PET/CT and PET/MRI with integrated perfusion measurement in CT and MR. Study aim is to gain knowledge about additional value of CT perfusion and MR perfusion in solid tumors concerning tumor physiology, diagnostic accuracy and possibly prognostic.

Enrollment: 43 patients

Sex: All

Ages: 30 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• indication as stated above
• written informed consent
• patients with suspected or confirmed solid malignant tumors of the neck, chest or abdomen who have an indication for a PET/CT

Exclusion criteria

• pregnant or breast feeding women
• non compliance of the patient to follow the study instructions (e.g. hearing problems, dementia)
• Inclusion in another clinical trial 30 days prior to inclusion
• age < 30years
• contraindication for MRI (cardiac pacemaker, certain metal implants, claustrophobia
• known allergies to contrast CT or MRI contrast media
• patients with an glomerular filtration rate of < 60ml/min/1.73m2